Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03604666
Other study ID # K170702J
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date March 1, 2019

Study information

Verified date May 2018
Source Assistance Publique - Hôpitaux de Paris
Contact Romain BOSC, MD
Phone 0149812533
Email romain.bosc@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The number of surgical procedures performed in ambulatory hospitalization for cancers of the skin or breast is increasing for medical and economic reasons. But the protocols of care and the clinical pathways are poorly adapted for elderly patients with physical or cognitive impairment.

The goal of this study is to test the impact of an oncology ambulatory surgical care in patients aged 75 years or older, with breast or skin cancer and treated in Henri Mondor hospital on the increase in the proportion of patients operated on an outpatient basis


Recruitment information / eligibility

Status Recruiting
Enrollment 320
Est. completion date March 1, 2019
Est. primary completion date March 1, 2019
Accepts healthy volunteers No
Gender All
Age group 75 Years and older
Eligibility Inclusion Criteria:

- Patient = 75 years old with breast cancer or skin cancer and requiring surgical excision: partial mastectomy, lumpectomy, axillary dissection, cutaneous excision, etc.

- With an indication of ambulatory care

- Patient (legal representative or trusted person or member of the family) having been informed and having given his non-oral objection to his participation in the study

- Possessing a health insurance

Exclusion Criteria:

- Patients reserved for breast reconstruction to the operative gesture of tumor resection.

- Patients do not consent to care because of deficient mental state.

- Formal surgical contraindication due to a pathology medical device does not allow anesthesia. - Participation in another interventional research or be in the exclusion period after a previous search, if applicable

Study Design


Intervention

Other:
Health care process with Nurse Navigator
A Nurse Navigator will: Be present at the announcement consultation Give information on the outpatient circuit Offer assistance for patients over 75 years Complete onco-geriatric orientation questionnaires Take care of patients on the ambulatory circuit

Locations

Country Name City State
France Bosc Créteil

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients operated on an outpatient basis Test the impact of an oncology ambulatory surgical care in patients aged 75 years or older, with breast or skin cancer and treated in Henri Mondor hospital 3 month
Secondary Number of death Test the impact of the new organization of care on the mortality at Day 30 and Day 90
Secondary Number of patients converted to conventional care Test the impact of the new organization of care on the proportion of patients converted to conventional care at Day 30 and Day 90
Secondary Number of the passage to emergencies Test the impact of the new organization of care on the passage to emergencies at Day 30 and Day 90
Secondary Number of not programmed hospitalizations Test the impact of the new organization of care on the not programmed hospitalizations at Day 30 and Day 90
Secondary The autonomy Activities of Daily Living (ADL) Test the impact of the new organization of care on the autonomy (ADL/IADL) at Day 30 and Day 90
Secondary The autonomy Instrumental Activities of Daily Living (IADL) Test the impact of the new organization of care on the autonomy (ADL/IADL) at Day 30 and Day 90
Secondary Number of institutionalization to Long-term care and skilled nursing facilities Test the impact of the new organization of care on the institutionalization to Long-term care and skilled nursing facilities at Day 30 and Day 90
Secondary Number of passage to Long-term care and skilled nursing facilities Test the impact of the new organization of care on the passage to Long-term care and skilled nursing facilities at Day 30 and Day 90
Secondary Number of postoperative complications Test the impact of the new organization of care on the postoperative complications at Day 90
Secondary Costs of care Test the impact of the new organization of care on the costs of care at Day 30 and Day 90
Secondary Patients' satisfaction (questionnaire) for the prospective part of the study Test the impact of the new organization of care on patients' satisfaction at Day 30 and Day 90
Secondary Patient's quality of life (EQ50 questionnaire, for the prospective part of the study) Test the impact of the new organization of care on quality of life (EQ50) (for the prospective part of the study) at Day 30 and Day 90
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A